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ABSTRACT
Background/aims Ageing of the population will result in
unprecedented numbers of older adults living with agerelated vision loss (ARVL). Self-management models
improve health outcomes and reduce healthcare costs;
however, the principles have rarely been applied in low
vision services.
Methods A two-armed randomised controlled trial of
older adults (n¼77) with ARVL compared ‘usual care’
provided by a not-for-profit community agency with an
extended model of care (usual care+self-management
group intervention). The primary outcome variable
(participation in life situations) was measured using the
Activity Card Sort. Secondary outcome measures
examined general health and vision-specific domains.
Results The intention-to-treat analysis demonstrated
that the extended model produced significantly better
participation in life situations at post-test when
compared with the usual care only group. Gains were
made regardless of whether participants were, or were
not, depressed at baseline. The addition of the selfmanagement group was also successful in significantly
reducing depression, increasing physical and mental
health, generalised and domain-specific self-efficacy, and
adjustment to ARVL. With the exception of adjustment
and mental health, differences were still apparent at
12 weeks’ follow-up.
Conclusion Addition of self-management significantly
improved general health and vision-specific rehabilitation
outcomes for older adults with ARVL.

studies (n¼532) with three follow-up studies.
Although all contained elements of self-management, only one was explicitly described as such.
Effect sizes for the outcomes ranged from small to
very large (0.14 to 1.21). The speciﬁc self-management programme was reported in two controlled
trials and a follow-up study.5e7 In the ﬁrst trial,
participation was effective in decreasing depression
and anxiety, increasing domain-speciﬁc self-efﬁcacy
and use of low vision aides in comparison with
a wait-list control group (n¼92).5 In the second trial
(n¼232), participation signiﬁcantly reduced
emotional distress and improved everyday functioning as compared with two control groups (12 h
of tape-recorded health information and a wait-list
control).6 Six-month follow-up revealed the
programme to be protective against development of
clinical depression.7 The systematic review
concluded, however, that there was a need for
studies with more robust methodology including an
intent-to-treat analysis.8 The primary objective of
this RCT was to evaluate the differential effects of
usual care (UC) and usual care plus vision selfmanagement (UC+VSM) on health and participation outcomes of older adults with ARVL. It was
judged unethical to withhold UC; hence a notreatment control group was not included. The
secondary objective was to examine the impact of
depression at pretest on the outcome variables.

MATERIALS AND METHODS

INTRODUCTION
Nearly half a million Australians have impaired
vision. With prevalence trebling with each decade
over age 60, this ﬁgure is projected to rise to 800 000
by 2024.1 In 2004, the direct costs were estimated at
$A1.8 billion, indirect costs at $A3.2 billion and the
cost of suffering and premature death a further
$A4.8 billion. In spite of critical advances in the
medical management of ocular pathology, many
people experience age-related vision loss (ARVL)
that is non-correctable. With a growing body of
research documenting negative impacts of ARVL on
the psychological, social and daily functioning of
older adults,2 3 effective interventions are needed.
Based on landmark qualitative research,4 selfmanagement programmes assist people in
managing their disease/symptoms, as well as the
emotional and daily consequences of living with
a chronic condition. Use of self-management in low
vision services is limited, but a recent systematic
review of education programmes for macular
degeneration found three protocols reported in four
Br J Ophthalmol 2010;94:223e228. doi:10.1136/bjo.2008.147538

A two-armed RCTevaluated UC in comparison with
UC+VSM, both provided by the Association for the
Blind of Western Australia (ABWA), a not-for-proﬁt
community low vision agency. ABWA provides
vision rehabilitation services to over 2000 Western
Australians annually who are blind or vision
impaired. Data collection occurred at baseline,
immediately after the completion of rehabilitation
and 12 weeks later (follow-up) (ﬁgure 1). Face-toface structured interviews (including oral administration of questionnaires) were administered in
participants’ homes. Ethical approval was obtained
from the Curtin University of Technology Human
Research Ethics Committee and the Chief Executive
Ofﬁcer of ABWA. All participants provided
informed consent and (1) were aged 65 or over, (2)
were diagnosed as having ARVL by an ophthalmologist, (3) had best corrected vision at the Snellen
equivalent of 6/12 or less in both eyes, (4) were
living in independent accommodation in the
community, (5) had sufﬁcient physical stamina,
mental functioning, hearing and communication
ability to attend the group intervention, and 6) were
newly referred to the agency or had recontacted the
223
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Figure 1 Flow of participants through
the trial.

Pretest and
Randomised
(n=77)

Allocation

VSM arm
(Experimental)
Allocated to VSM
(n= 36)
Received allocated
intervention (n=29)
Some incomplete data (n=1)

Allocated to Usual Care
(n= 41)
Received allocated
intervention (n=41)

Did not receive allocated
intervention (n=7)
Too ill (n=2)
Unable to attend due to
prior commitments (n=5)

Posttest

Lost to follow-up
Poor health (n=1)

Lost to follow-up
Poor health (n=1)

Discontinued intervention
No longer interested (n=1)

Posttest (n=40)

Analysis

Follow-up

Posttest (n=35)

Follow-up (n=35)

Follow-up (n=40)

Intent-to-treat analysis (n=36)

Intent-to-treat analysis (n=41)

On-protocol analysis (n=27)

On-protocol analysis (n=40)

agency after a signiﬁcant deterioration in their vision (deﬁned as
‘need for new low vision aids’). Allocation was by random
assignment via computer-generated random numbers table.
Socio-demographic data and participant clinical characteristics
were collected at baseline. The independent variable was intervention type (UC or UC+VSM) (table 1). For details of the needs
assessment, see Girdler et al9 and details of the intervention see
Packer et al.10

Participation
11

The original Activity Card Sort (ACS) was used to measure the
primary outcome variabledparticipation levels. Images and
descriptions of everyday activities were digitally magniﬁed on
a laptop computer. A standardised description of each image was
read to participants unable to see the screen. Testeretest reliability (r¼0.90) has been reported in a sample of 20 community
dwelling older adults,11 and construct validity has been established in various samples of older adults.12 Current activity level
as outlined in the Test Manual was calculated.

Table 1

Usual Care arm
(Control)

Depression
Developed for use with people over the age of 60, the widely
used 30-item Geriatric Depression Scale (GDS) includes fewer
somatic items than other scales.13 It has excellent internal
consistency (a¼0.94), 1-week testeretest reliability (r¼0.85) and
concurrent validity with the Zung Self-Rating Depression Scale
(r¼0.83) and the Hamilton Rating Scale for Depression (r¼0.84).14

Quality of life
Quality of life was measured with the Australia/New Zealand version
of the SF-36 Health Survey (Version 1.0).15 Physical Component
Summary (PCS) and Mental Component Summary (MCS) scores
were calculated16 using a customised SAS/STAT programme based
on Australian normative data (mean¼50, SD¼10).17

Generalised self-efficacy
Participants’ strength of belief in ability to manage a wide range
of everyday problems and difﬁculties was measured with the
Generalised Self-Efﬁcacy Scale (GSES).18 Schwarzer18 demonstrated the unidimensionality of the scale, a high level of internal

Key features of the interventions

Usual care

Usual care+vision self-management programme

< One-to-one case management model
< Initial interview in client’s home by service coordinator to discuss service needs

< Based on local qualitative study,9 included self-management, self-efficacy and

and to jointly develop service plan

< Visual assessment at low-vision clinic by optometrists and orthoptists;

prescription of low-vision aids; aids provided on a trial basis.

< Referral to internal (occupational therapy, orthopty, social work, orientation and

mobility training, low-vision technology) and external service providers

224

‘Usual care,’ plus self-management:
group model of service delivery theories and principles

< 8-week (24 h) structured programme of welcome and warm-up exercises,

revision of homework, learning sessions (including learning and practice activities)
and homework assignments
< Delivered in a group environment with six to 10 participants, and led by an
occupational therapist and a social worker

Br J Ophthalmol 2010;94:223e228. doi:10.1136/bjo.2008.147538
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consistency (a¼0.93), and the absence of gender bias in mean
scale scores in a sample (n¼249) of older adults. The English
version has been supported by Barlow et al,19 who reported
a high internal consistency (a¼0.88) and testeretest reliability
of 0.63.

Adaptation
The Adaptation to Vision Loss Scale (AVLS)20 is a measure of
adaptation to vision loss, low visual rehabilitation (LVR) and
relationships with family and friends. It has a good internal
consistency (a¼0.84) and reliability (a¼0.83).21 It is sufﬁciently
sensitive to record positive changes following provision of vision
rehabilitation services.21

Domain-specific self-efficacy
Vision-speciﬁc self-efﬁcacy was measured using the Macular
Degeneration Self-Efﬁcacy Questionnaire (AMD-SEQ)5 adapted
(with permission) to reﬂect generic ARVL (ARVL-SEQ). The
AMD-SEQ is internally consistent (a ranging from 0.60 to 0.74)
and reliable over 2 days (r¼0.70 to 0.88) and 6 weeks (r¼0.59 to
0.89).5 It is sufﬁciently sensitive to record positive change at posttest and 6 months following participation in a self-management
intervention.6 7
Using pilot data,10 a power calculation for analysis of variance
(80% power and 5% signiﬁcance) determined the need for 38
participants per group. Statistical analyses were performed using
SPSS version 12.0.1 (SPSS, Chicago). All analyses, unless otherwise stated, were conducted on an intention-to-treat basis22 (see
ﬁgure 1). Missing data were imputed using either carry forward
or mean substitution.
Baseline socio-demographic and clinical characteristics of the
two groups were compared using independent sample t tests
for continuous variables, c2 tests for independence and Fisher
exact tests for categorical variables. Analysis of covariance
(ANCOVA) with pretest scores as covariate examined effectiveness (primary and secondary outcomes). Normality and homogeneity of variance were tested and, where necessary, data
transformations performed. Effect size was measured using
partial eta squared and was interpreted based on Cohen’s
proposed conventional values for analysis of covariance:
small¼0.10, medium¼0.3 and large¼0.50.23 The number of
participants depressed (GDS$11) versus not depressed in each
group was compared at each data collection point using the c2
test for independence. Statistical signiﬁcance for all tests was set
a priori at 0.05.
To examine the interaction between the model of service
delivery and clinically signiﬁcant symptoms of depression at
pretest on the primary outcome measure, a two-way ANCOVA
was performed. The type of intervention and depression (yes/no
based on a GDS$11) were entered as ﬁxed factors, pretest ACS
scores as the covariate, and post-test and follow-up ACS scores as
dependent variables.

RESULTS
Thirty-six participants were allocated to UC+VSM and 41 to UC
(ﬁgure 1). Seven participants did not attend the self-management
programme as allocated due to illness (n¼2) or prior commitments (n¼5). They were, however, included in the intent-totreat analysis. Of those who began the VSM programme as
allocated (n¼29) attendance was high; ﬁve participants missed
one session each, and one participant missed two. One participant was lost to follow-up in each group.
The random number generation model resulted in slightly
different participant numbers in the two groups. There were no
Br J Ophthalmol 2010;94:223e228. doi:10.1136/bjo.2008.147538

signiﬁcant differences between groups on any measured characteristic. The mean age was 79.1 years (SD¼6.7), which reﬂects
the age-related nature of visual impairment. Also reﬂective of
ageing, only 18% of participants reported vision impairment as
their sole medical condition. The primary cause of vision
impairment, age-related macular degeneration, reﬂects that in an
Australian population.24 Sixty-six per cent of participants rated
their health as good, very good or excellent (table 2).
Participants in the experimental group had statistically better
participation levels than the control group (table 3). Over the course
of the study UC+VSM participants demonstrated an increase, then
maintenance of participation in life situations, while UC participants experienced gradual decline. At post-test, those in the UC
+VSM demonstrated a 5% increase in participation, while those
receiving UC alone experienced a 5% decline (effect size¼0.20);
differences were sustained at 12 weeks follow-up (p<0.001).
Secondary outcomes included general health measures (GDS,
QOL and GSES) and vision-speciﬁc measures (AVLS and ARVLSEQ). On all general health measures, the UC+VSM group
demonstrated signiﬁcantly better outcomes than the UC group
at post-test, with differences retained at follow-up. On the GDS
the adjusted pretest score (mean¼10.58) was close to the 11 cutoff for clinically signiﬁcant symptoms. In the experimental
group, this dropped to 8.05 at post-test, with the 95% CI falling
completely below the 11-point cut-off, both a clinically and
a statistically signiﬁcant improvement. In contrast, the mean
score for the control group rose above the clinical cut-off
(adjusted GDS mean¼11.28). Analysis of depression as a dichotomous variable (depressed vs not depressed) revealed that at posttest, 51% of participants in the control group were depressed
compared with only 36% of the UC+VSM participants. By
12 weeks’ follow-up, only 17% of the experimental group
(compared with 51% of controls) were experiencing symptoms
of depression (c2¼0.002, p¼0.000).
At post-test, the UC+VSM participants also demonstrated
signiﬁcantly better physical and mental health (measured by the
SF-36 PCS and MCS scores) and generalised self-efﬁcacy (GSES)
when compared with the control group (p#0.019 to 0.001).
Scores remained largely unchanged from post-test to follow-up
with UC+VSM participants continuing to demonstrate better
outcomes. The one exception was mental health, where a slight
improvement in scores of the UC group (SF-36 MCS) resulted in
the loss of signiﬁcance (p¼0.102) between the two groups. The
extremely small effect size of 0.03 and a power of 36%, suggests
that this was related to statistical power.
On the two vision-speciﬁc measures (AVLS and ARVL-SEQ)
post-test results again demonstrated better outcomes for the UC
+VSM participants (p#0.001) with medium effect sizes. An
increase in scores of the UC group resulted in loss of signiﬁcance
(p¼0.058) at follow-up.
To examine the interaction between type of service and
presence of baseline depression scores, a two-way ANCOVA was
performed: assumptions of normality, homogeneity of variance
and reliability of measurement of the covariate were met. The
independent variables were allocation (UC+VSM or usual care)
and depression at pretest (depressed or non-depressed), and the
dependent variable was participation in life situations (ACS) at
post-test and follow-up. Baseline ACS scores were entered as
a covariate. Results indicated a signiﬁcant main effect for allocation at post-test (F(1,73)¼19.02, p<0.001, partial eta
squared¼0.21) and at follow-up (F(1,73)¼32.79, p<0.001, partial
eta squared¼0.31). Participants in the UC+VSM had signiﬁcantly higher levels of participation in life situations than those
who received UC only at post-test and follow-up, irrespective of
225
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Table 2

Socio-demographic and clinical characteristics of all randomised participants at pretest

Socio-demographic characteristics
Age, years*
Mean (SD)
Range
Gender
Male
Female
Marital status
Not married
Married or de facto
Living situation
Alone
With others
Education
Primary or less
Secondary school
Tertiary or vocational
Income (weekly)
#300
300+
Country of birth
Australia/New Zealand
UK
Other
Clinical characteristics
Health conditions
Vision loss only
Additional medical condition/s
Total no of health conditions
Mean (SD)*
Self-rated health
Excellent/very good
Good
Fair
Received low visual rehabilitation previously
Yes
No
Age when vision loss affected daily activities, mean (SD)*
Years since vision loss affected daily activities
One or less
More than one
Primary diagnosis
Age-related macular degeneration
Other eye disease
Visual impairment
Mild
Moderate
Severe
Log of weighted visual acuity*, mean (SD)
Log of worst eye, mean (SD)*
Log of best eye mean (SD)*
Subjective visual impairmenty
Fair
Poor
Depressed
Yes
No

VSM (n[36)

Usual care (n[41)

All participants (n[77)

79.4 (7.2)
65 to 92

80.4 (6.3)
65 to 97

79.1 (6.7)
65 to 97

10 (27.8)
26 (72.2)

17 (41.5)
24 (58.5)

27 (35.1)
50 (64.9)

23 (63.9)
13 (36.1)

24 (58.5)
17 (41.5)

47 (61.0)
30 (39.0)

23 (63.9)
13 (36.1)

23 (56.1)
18 (43.9)

46 (59.7)
31 (40.3)

19 (52.8)
7 (19.4)
10 (27.8)

15 (36.6)
14 (34.1)
12 (29.3)

34 (44.2)
21 (27.3)
22 (28.6)

25 (69.4)
11 (30.6)

23 (56.1)
18 (43.9)

48 (62.3)
29 (37.7)

22 (61.1)
8 (22.2)
6 (16.7)

31 (75.6)
6 (14.6)
4 (9.8)

53 (68.8)
14 (18.2)
10 (13.0)

7 (19.4)
29 (80.5)
54
1.8 (0.8)

7 (17.1)
34 (82.9)
69
2.0 (0.9)

14 (18.2)
63 (81.8)
123
1.6 (1.1)

6 (16.7)
16 (44.4)
14 (38.9)

15 (36.6)
14 (34.1)
12 (29.3)

21 (27.3)
30 (39.0)
26 (33.8)

6 (16.7)
30 (83.3)
77.3 (7.0)

10 (24.4)
31 (75.6)
77.2 (7.9)

16 (20.8)
61 (79.2)
77.3 (7.5)

20 (55.5)
16 (44.4)

18 (43.9)
23 (56.1)

38 (49.4)
39 (50.6)

26 (72.2)
10 (27.8)

35 (85.4)
6 (14.6)

61 (79.2)
16 (20.8)

9 (25.0)
13 (36.1)
14 (38.9)
0.97 (0.50)
1.41 (0.79)
0.82 (0.48)

7 (17.1)
21 (51.2)
13 (31.7)
1.0 (0.46)
1.54 (0.77)
0.82 (0.45)

16 (20.8)
34 (44.1)
27 (35.1)
0.98 (0.47)
1.48 (0.78)
0.82 (0.46)

7 (19.4)
29 (80.5)

3 (7.3)
38 (92.7)

10 (13.0)
67 (87.0)

18 (50.0)
18 (50.0)

15 (36.6)
26 (63.4)

33 (42.9)
44 (57.1)

Significance
0.53

0.21

0.63

0.49

0.26

0.23

0.30

0.79

0.46
0.15

0.40

0.94
0.31

0.16

0.40

0.79
0.48
0.98
0.11

0.24

*Independent-samples t test.
yFischer exact test.

whether or not they had clinically signiﬁcant symptoms of
depression at pretest. No statistically signiﬁcant main effect for
depression was found at either time (post-test F(1,73)¼0.07,
p¼0.78; follow-up F(1,73)¼0.05, p¼0.83).
226

DISCUSSION
The addition of the self-management programme to UC resulted
in better general and vision-speciﬁc outcomes. With the exception of adjustment to vision loss and mental health, these
Br J Ophthalmol 2010;94:223e228. doi:10.1136/bjo.2008.147538
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Table 3 Results of ANCOVA comparing usual care (UC) and usual care plus vision self-management (experimental group) (UC+VSM) and UC on
primary and secondary outcomes at post-test and follow-up (pretest scores used as a covariate)
Measure
Primary outcome measure
ACS*
Secondary outcome measures
General health domain
Geriatric Depression Scaley
SF-36
Physical Component Summary*
Mental Component Summary*
Generalised Self-Efficacy Scale*
Vision-specific domain
Adaptation to Vision Loss Scale*
Age-related vision loss-Self-Efficacy
Questionnaire

Group

Pretest
Adjusted Mean

Post-test
Mean

Follow-up
Effect sizez

p Value

Mean

Effect sizez

p Value

UC+VSM
UC

0.67
0.67

0.72
0.62

0.20

0.001

0.72
0.56

0.31

0.001

UC+VSM
UC

10.58
10.58

8.05
11.28

0.17

0.001

7.52
10.83

0.18

0.001

UC+VSM
UC
UC+VSM
UC
UC+VSM
UC

36.07
36.07
51.94
51.94
29.56
29.56

38.16
33.29
56.32
51.71
31.55
27.75

0.10

0.005

0.23

0.001

0.07

0.019

0.03

0.102

0.20

0.001

38.86
31.43
56.13
53.49
31.08
27.59

0.14

0.001

UC+VSM
UC
UC+VSM
UC

52.67
52.67
54.10
54.10

61.16
49.68
78.81
59.35

0.27

0.001

0.05

0.058

0.30

0.001

62.10
55.71
80.14
58.58

0.30

0.001

*Increasing scores¼Improvement.
yDecreasing scores¼Improvement.
zSmall¼0.10, medium¼0.3, large¼0.50.23

differences were still apparent at 12 weeks’ follow-up. Participation in life situations, as measured with the ACS, is of
particular importance. The observed decline experienced by
participants who received UC over the short period of the study
(20e24 weeks) is alarming. The addition of self-management
appears to not only arrest decline but also increase participation
in life situations. This ﬁnding supports the assertion that
participation in life situations is modiﬁable.
In the ﬁeld of LVR, considerable debate surrounds the inﬂuence of depression on readiness for rehabilitation.3 While some
have argued that rehabilitation should be delayed until depression has been treated,24 others have asserted that rehabilitation
has a key role in reducing depression.7 Participants in the UC
+VSM group increased their participation in life situations,
irrespective of whether they reported clinically signiﬁcant pretest
symptoms of depression. UC+VSM was effective in reducing
both the symptoms of depression and the number of participants
with clinically signiﬁcant symptoms, whereas UC alone was not,
suggesting that the model of service delivery inﬂuences outcomes
more than prerehabilitation depression.
The QOL of the two groups of participants demonstrated
divergent trends. At both post-test and follow-up, the UC+VSM
had signiﬁcantly better mood, less psychological distress, and
fewer social or role limitations due to emotional problems (SF 36
MCS). At follow-up, the UC+VSM participants, but not the UC
group, reported PCS scores similar to community dwelling peers
without vision impairment.17
At follow-up, both groups showed improved adaptation to
vision loss, results similar to those from other research.20 21
However, the UC+VSM group appeared to adapt more quickly,
with the two groups being signiﬁcantly different at post-test.
Others have also reported immediate beneﬁts following participation in a group-based LVR.21
In the present study, the greatest magnitude of change reported
by the UC+VSM group was domain-speciﬁc self-efﬁcacy (ARVLSEQ). In comparison, those who received UC demonstrated only
small improvements. It is acknowledged that self-management
Br J Ophthalmol 2010;94:223e228. doi:10.1136/bjo.2008.147538

programmes aim to increase self-efﬁcacy; however, this dramatic
increase accompanied by improvements in activity participation
and depression levels further supports the assertion that selfefﬁcacy is critical in mediating outcomes.7
Caution must be exercised when generalising ﬁndings.
Participation was limited to community-dwelling older adults
with ARVL within one geographical location, and all had chosen
to seek LVR services. However, the sample appears to match the
age, gender and vision diagnosis of older Australians.24 Selfselection bias is a common concern in behavioural interventions,
but this reﬂects the reality of behavioural interventions in clinical
practice.25 Although the assessor was masked to participants’
group allocation, participants often inadvertently revealed their
allocation during post-test and follow-up interviews. The quantitative self-report nature of outcomes reduced the potential bias
to some extent. Finally, it is important to highlight that selfmanagement was provided in addition to usual care. It is possible
that the effectiveness of the programme lies in the interaction
between these two models of service delivery.

CONCLUSION
The present study has important strengths. Use of UC+VSM
demonstrated clinically and statistically better health outcomes
than UC alone. Importantly, the demonstrated declines experienced by the UC group were not seen in the UC+VSM group
who made positive improvements. The conservative intentionto-treat approach adds conﬁdence in the evidence of effectiveness
demonstrated.
The present study demonstrated not only the effectiveness, but
also the feasibility of delivering self-management programmes
within a real service environment. Although conducting research
in an ‘in vivo’ situation posed many challenges, it demonstrated
that research in this ﬁeld can be relevant and rigorous.
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